Overview

A Pharmacokinetic Study of an Experimental Paracetamol Formulation

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This PK study is designed to show bioequivalence between the study treatments.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Acetaminophen
Caffeine